These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8516661

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Factors affecting short- and long-term outcome of a short therapeutic trial with cisapride in dyspeptic patients.
    Heyse PM, Rambaldo R, Hazelhoff B.
    Scand J Gastroenterol Suppl; 1993; 195():15-23; discussion 23-4. PubMed ID: 8516654
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients.
    Wood SF, Penney SC, Cochran KM.
    Scand J Gastroenterol Suppl; 1993; 195():5-10. PubMed ID: 8516659
    [Abstract] [Full Text] [Related]

  • 7. Risk factors, co-medication, and concomitant diseases: their influence on the outcome of therapy with cisapride.
    Fehr HF.
    Scand J Gastroenterol Suppl; 1993; 195():40-5; discussion 45-6. PubMed ID: 8516657
    [Abstract] [Full Text] [Related]

  • 8. [Interdigestive migrating complex (IMC) and effect of cisapride in patients with non-ulcer dyspepsia (NUD)].
    Sekiguchi T, Horikoshi T, Nishioka T, Kusano M, Matsuzaki T, Kawamura O, Miyazaki M, Kikuchi K.
    J Smooth Muscle Res; 1991 Jun; 27(3):131-7. PubMed ID: 1840866
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.
    Rezende-Filho J, Di Lorenzo C, Dooley CP, Valenzuela JE.
    Dig Dis Sci; 1989 Jul; 34(7):1057-62. PubMed ID: 2743845
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Functional dyspepsia versus other functional gastrointestinal disorders: a practical approach in Belgian general practices.
    Verhaeghe J, Jaecques N, Rombouts J, Spaepen W, Cardon E, Lebrun F, Meurant JP.
    Scand J Gastroenterol Suppl; 1993 Jul; 195():25-34; discussion 34-5. PubMed ID: 8516655
    [Abstract] [Full Text] [Related]

  • 15. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC, MacCannell KL, Thomson AB, Tanton R, Eberhard S, Sullivan SN, Archambault A.
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial.
    Mearin F, Rodrigo L, Pérez-Mota A, Balboa A, Jiménez I, Sebastián JJ, Patón C.
    Clin Gastroenterol Hepatol; 2004 Apr; 2(4):301-8. PubMed ID: 15067624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.